Canada markets closed

Cosmo Pharmaceuticals N.V. (C43.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
72.500.00 (0.00%)
At close: 02:45PM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
10,840
17,225
21,672
-7,901
Depreciation & amortization
13,963
13,856
7,369
6,035
Stock based compensation
2,296
2,077
1,457
8,995
Change in working capital
-9,045
-13,314
-5,072
-5,138
Inventory
1,551
1,621
-6,072
436
Other working capital
23,969
25,916
4,107
4,900
Other non-cash items
6,700
6,837
6,214
4,153
Net cash provided by operating activites
36,141
33,226
12,611
12,985
Cash flows from investing activities
Investments in property, plant and equipment
-12,172
-7,310
-8,504
-8,085
Acquisitions, net
-
0
-2,615
-4,122
Purchases of investments
-117,706
-54,049
-1,002
-20,013
Sales/Maturities of investments
15,578
35,915
7,737
131,615
Net cash used for investing activites
-89,109
1,689
24,857
75,446
Net change in cash
-
-11,218
10,221
76,547
Cash at beginning of period
218,027
198,560
185,937
110,387
Cash at end of period
125,690
185,825
198,560
185,937
Free Cash Flow
Operating Cash Flow
36,141
33,226
12,611
12,985
Capital Expenditure
-12,172
-7,310
-8,504
-8,085
Free Cash Flow
23,969
25,916
4,107
4,900